Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 582751, 16 pages
http://dx.doi.org/10.1155/2015/582751
Research Article

Chinese Herbal Medicine Combined with Conventional Therapy for Blood Pressure Variability in Hypertension Patients: A Systematic Review of Randomized Controlled Trials

1Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China
2Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China
3Cardiovascular Diseases Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China

Received 21 August 2014; Revised 24 September 2014; Accepted 24 September 2014

Academic Editor: Myeong Soo Lee

Copyright © 2015 Zhuo Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. M. Rothwell, S. C. Howard, E. Dolan et al., “Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension,” The Lancet, vol. 375, no. 9718, pp. 895–905, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Tsioufis, I. Andrikou, C. Thomopoulos, D. Petras, A. Manolis, and C. Stefanadis, “Comparative prognostic role of nighttime blood pressure and nondipping profile on renal outcomes,” American Journal of Nephrology, vol. 33, no. 3, pp. 277–288, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Parati, X. Liu, and J. E. Ochoa, “Clinical relevance of visit-to-visit blood pressure variability: impact on renal outcomes,” Journal of Human Hypertension, vol. 28, pp. 403–409, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Muntner, D. Shimbo, M. Tonelli, K. Reynolds, D. K. Arnett, and S. Oparil, “The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994,” Hypertension, vol. 57, no. 2, pp. 160–166, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Mancia, G. Parati, M. Hennig et al., “Relation between blood pressure variability and carotid artery damage in hypertension: Baseline data from the European Lacidipine Study on Atherosclerosis (ELSA),” Journal of Hypertension, vol. 19, no. 11, pp. 1981–1989, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. A. J. Webb, U. Fischer, Z. Mehta, and P. M. Rothwell, “Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis,” The Lancet, vol. 375, no. 9718, pp. 906–915, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, “The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT),” The Journal of the American Medical Association, vol. 288, no. 23, pp. 2981–2997, 2002. View at Publisher · View at Google Scholar
  8. H.-H. Xie, F.-M. Shen, L.-P. Xu, P. Han, C.-Y. Miao, and D.-F. Su, “Reduction of blood pressure variability by combination therapy in spontaneously hypertensive rats,” Journal of Hypertension, vol. 25, no. 11, pp. 2334–2344, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Sega, G. Corrao, M. Bombelli et al., “Blood pressure variability and organ damage in a general population: results from the PAMELA study,” Hypertension, vol. 39, no. 2, pp. 710–714, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. Z. Y. Zhao, Z. Y. Zhao, Y. Q. Wang, Z. H. Yan, J. Cui, and Y. Y. Li, “Quantitative study of circadian variations of ambulatory blood pressure in Chinese healthy, hypertensive, and diabetes subjects,” Clinical and Experimental Hypertension, vol. 27, no. 2-3, pp. 187–194, 2005. View at Google Scholar
  11. Y. Liu, J. C. Zhang, D. Z. Shi et al., “Fluctuant hypertension and platelet activation: current situations and control strategies with integrative medicine,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 33, no. 7, pp. 869–872, 2013. View at Google Scholar
  12. World Health Organization and International Society of Hypertension Writing Group, “2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension,” Clinical and Experimental Hypertension, vol. 21, no. 5-6, pp. 1009–1060, 1999. View at Publisher · View at Google Scholar
  13. World Health Organization and International Society of Hypertension Writing Group, “2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension,” Journal of Hypertension, vol. 21, no. 11, pp. 1983–1992, 2003. View at Google Scholar
  14. Chinese Hypertension Prevention Guide Revision Committee, Chinese Hypertension Prevention Guide (2005 Revision), People's Health Publishing House, Beijing, China, 2006.
  15. Chinese Hypertension Prevention Guide Revision Committee, “Chinese hypertension prevention guide 2010,” Chinese Jounal of Hypertension, vol. 19, no. 8, pp. 701–708, 2011. View at Google Scholar
  16. J. P. T. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0, The Cochrane Collaboration, Oxford, UK, 2011, http://handbook.cochrane.org/.
  17. L. M. Pan, The Study of TCM Syndromes in Elderly Hypertensive Patients and Evaluation between Syndromes and Blood Pressure Variability and Treatment with TCM, China Academy of Chinese Medical Sciences, Beijing, China, 2012.
  18. N. S. Ma, Study on Influence of Qian Yang Yu Yin Granules on Blood Pressure Variability of the Patients with Hypertension, Nanjing University of Chinese Medicine, Nanjing, China, 2013.
  19. L. Liang, Clinic Study on the Effects of Qin Dan Capsule in Treating Essential Hypertension Patients of “Liver Fire and Blood Stagnation”, Shandong University, Jinan, China, 2007.
  20. M. Shi, The Clinical Study of Sang Ji Wen Dan Decoction Treatment on Hypertension in Old Patients with Liver Yang Hyper Activity and Phlegm-Fire Syndrome, Nanjing University of Chinese Medicine, Nanjing, China, 2011.
  21. F. Q. Wang, “Efficacy observation of Song ling xue mai kang combined with amlodipine in treating essential hypertension patients,” Jilin Journal of Traditional Chinese Medicine, vol. 31, no. 2, pp. 149–150, 2011. View at Google Scholar
  22. X. X. Kang and P. Fan, “The treatment of Xian Dan Tong Mai decoction in elderly hypertension patients,” Shandong Journal of Traditional Chinese Medcine, vol. 32, no. 10, pp. 723–725, 2013. View at Google Scholar
  23. L. Ma, J. He, and H. B. Li, “The impact of Xiang Tian Ma decoction on blood pressure variability in patients of deficiency of Yin and internal dry,” Xinjiang Journal of Traditional Chinese Medicine, vol. 31, no. 1, pp. 11–13, 2013. View at Google Scholar
  24. Y. L. Li, “Effects of combined application of xuezhikang capsule with hypotensive drug on ambulatory blood pressure and blood pressure Variability,” Guide of China Medicine, vol. 10, no. 6, pp. 41–43, 2012. View at Google Scholar
  25. R. L. Ji and Q. H. Han, “Efficacy research on Yang xue qing nao particles in patients with hypertension,” Chinese Journal of Integrative Medicine on Cardio-cerebrovascular Disease, vol. 9, no. 3, pp. 263–265, 2011. View at Google Scholar
  26. W. N. Zhang, H. F. Huang, and X. Z. Tang, “Influence of medicine leading to the liver channel in antihypertensive efficacy of amlodipine in the elderly hypertensive patients,” in The Tenth TCM Academic Communication of Prevention and Treatment of Senile Diseases, Xianmen, China, 2012. View at Google Scholar
  27. Z. Q. Yan, The Effect of Tiao Ping Kang Discus in Diurnal Rhythm and the Clinical Therapeutic Effect in Essential Hypertension Patients, Guangzhou University of Chinese Medicine, Guangzhou, China, 2008.
  28. C. G. Liang, The Study on the “Gou Teng Si Wu Tang” Treating Level 1,2 Elderly Hypertension, Shandong University of Chinese Medicine, Jinan, China, 2011.
  29. J. Chen, The Intervention Effects of Qingxuan Granule on Endothelial Injury Induced by Inflammatory Reaction of Hypertensive Patients, China Academy of Chinese Medical Sciences, Beijing, China, 2012.
  30. X.-G. Sun, W.-K. Wu, and Z.-P. Lu, “Chinese integrative medicine: translation toward person-centered and balanced medicine,” Chinese Journal of Integrative Medicine, vol. 18, no. 1, pp. 3–6, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. S.-L. Chen, X.-Y. Liu, W.-M. Xu, W.-Y. Mei, and X.-L. Chen, “Clinical study of Western medicine combined with Chinese medicine based on syndrome differentiation in the patients with polarized hypertension,” Chinese Journal of Integrative Medicine, vol. 18, no. 10, pp. 746–751, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Freemantle, M. Calvert, J. Wood, J. Eastaugh, and C. Griffin, “Composite outcomes in randomized trials: greater precision but with greater uncertainty?” The Journal of the American Medical Association, vol. 289, no. 19, pp. 2554–2559, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. L. L. Kjaergard, J. Villumsen, and C. Gluud, “Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses,” Annals of Internal Medicine, vol. 135, no. 11, pp. 982–989, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. K. F. Schulz, D. G. Altman, and D. Moher, “CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials,” Annals of Internal Medicine, vol. 152, no. 11, pp. 726–732, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. J. J. Gagnier, H. Boon, P. Rochon, D. Moher, J. Barnes, and C. Bombardier, “Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement,” Annals of Internal Medicine, vol. 144, no. 5, pp. 364–367, 2006. View at Publisher · View at Google Scholar · View at Scopus